Also trades as: HLOSF (OTC) · $vol 0M
4593.T JPX
Healios K.K.
1W: -1.0%
1M: +0.0%
3M: +13.4%
YTD: -25.1%
1Y: -54.4%
3Y: +2.5%
5Y: -84.2%
¥289.00 ($1.83)
+2.00 (+0.70%)
Weekly Expected Move ±7.1%
¥247
¥267
¥287
¥307
¥327
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$104M
-81.4% ▼
5Y CAGR: +31.0%
Gross Profit
-$389M
-190.0% ▼
Operating Income
-$3.4B
-17.3% ▼
Net Income
-$2.2B
+47.7% ▲
EPS (Diluted)
$-20.59
+57.0% ▲
EBITDA
-$3.1B
-22.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $41M | $90M | $121M | $560M | $104M |
| YoY Growth | +51.9% | +119.5% | +34.4% | +362.8% | -81.4% |
| Cost of Revenue | $0 | $0 | $13M | $128M | $493M |
| Gross Profit | $41M | $90M | $108M | $432M | -$389M |
| Gross Margin | 100.0% | 100.0% | 89.3% | 77.1% | -374.0% |
| R&D Expenses | $3.7B | $3.8B | $2.3B | $2.0B | $2.0B |
| SG&A Expenses | $1.7B | $1.4B | $1.2B | $1.4B | $990M |
| Operating Expenses | $5.4B | $5.3B | $3.5B | $3.3B | $3.0B |
| Operating Income | -$5.4B | -$5.2B | -$3.4B | -$2.9B | -$3.4B |
| Operating Margin | -13131.7% | -5754.4% | -2792.6% | -518.2% | -3272.1% |
| Interest Expense | $802M | $500M | $704M | $1.6B | $200M |
| Income Before Tax | -$4.5B | -$5.3B | -$3.6B | -$4.1B | -$2.1B |
| Tax Expense | $450M | -$160M | $187M | $166M | $103M |
| Net Income | -$4.9B | -$5.2B | -$3.8B | -$4.2B | -$2.2B |
| Net Margin | -11980.5% | -5744.4% | -3159.5% | -756.2% | -2131.7% |
| EPS (Diluted) | $-93.36 | $-90.69 | $-56.22 | $-47.86 | $-20.59 |
| EBITDA | -$3.6B | -$4.5B | -$3.2B | -$2.5B | -$3.1B |
| Shares Outstanding | 53M | 57M | 68M | 88M | 108M |